U.S., Jan. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07354100) titled 'Lactulose to Improve Gut Health in Cancer Patients Receiving Immunotherapy' on Jan. 15.
Brief Summary: The purpose of this study is to see if lactulose can improve the effectiveness of immunotherapy in patients with advanced cancer.
Study Start Date: Jan. 15
Study Type: INTERVENTIONAL
Condition:
Cancer
Intervention:
DRUG: Lactulose
Lactulose 10 g daily with standard-of-care Immune checkpoint inhibitors (ICIs).
Recruitment Status: NOT_YET_RECRUITING
Sponsor: University of Chicago
Disclaimer: Curated by HT Syndication....